Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR)

ClinicalTrials.gov ID: NCT01654536

Public ClinicalTrials.gov record NCT01654536. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 5:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 6 Month Randomized, Open Label, Parallel Group, Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a 6 month, multicenter, randomized, open label, parallel group, study to evaluate the nasal safety of ciclesonide nasal aerosol and ciclesonide aqueous nasal spray administered once daily to male and female subjects 12 years and older diagnosed with PAR.

Study identification

NCT ID
NCT01654536
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
737 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2012
Primary completion
Jun 30, 2013
Completion
Jun 30, 2013
Last update posted
Jul 23, 2014

2012 – 2013

United States locations

U.S. sites
31
U.S. states
16
U.S. cities
29
Facility City State ZIP Site status
Allergy & Asthma Associates of Southern California Mission Viejo California 92691
CHOC PSF AMC - Division of Allergy, Asthma and Immunology Orange California 92868
Allergy Associates Medical Group Inc. San Diego California 92120
Bensch Research Associates Stockton California 95207
Storms Clinical Research Institute Colorado Springs Colorado 80907
DataQuest Medical Research LLC Lawerenceville Georgia 30046
Asthma & Allergy Consultants, PC Lilburn Georgia 30047
Gordon D Raphael, MD Bethesda Maryland 20814
Medical Education and Research Management Services of New England Gardner Massachusetts 01440
Northeast Medical Research Associates, Inc. North Dartmouth Massachusetts 02747
Respiratory Medicine Research Institute of Michigan, PLC Ypsilanti Michigan 48197
Clinical Research Institute Inc. Minneappolis Minnesota 55402
The Clinical Research Center, LLC St Louis Missouri 63141
Clinical Research Group of Montanta Bozeman Montana 59718
Ocean Allergy & Respiratory Research Center Brick New Jersey 08724
Atlantic Research Center, LLC Ocean City New Jersey 07721
Princeton Center for Clinical Research Skillman New Jersey 08558
Allergy and Asthma Center of NC, PA High Point North Carolina 27262
North Carolina Clinical Research Raleigh North Carolina 27607
Allergy Assocaites Research Center Portland Oregon 97202
Valley Clinical Research Center Bethlehem Pennsylvania 18020
Asthma and Allergy Research Associates Upland Pennsylvania 19013
National Allergy, Asthma & Uticaria Centers of Charleston, P.A. Charleston South Carolina 29406
Isis Clinical Research, LLC Austin Texas 78731
Sirius Clinical Research LLC Austin Texas 78759
Pharmaceutical Research and Consulting Inc. Dallas Texas 75231
Kerrville Research Associates, PA Kerrville Texas 78028
Central Texas Health Research New Braunfels Texas 78130
Biogenics Research Institute San Antonio Texas 78229
Sylvana Research Associates San Antonio Texas 78229
ASTHMA Inc. Clinical Research Center Seattle Washington 98115

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01654536, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 23, 2014 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01654536 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →